aldosterone has been researched along with cilazapril, anhydrous in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beretta-Piccoli, C; Bernasconi, M; Lepori, G; Marone, C; Shaw, S; Weidmann, P | 1 |
| Ferrannini, E; Galvan, AQ; Gazzetti, P; Masoni, A; Natali, A; Santoro, D | 1 |
| Brown, AN; Brunner, DB; Brunner, HR; Fasanella d'Amore, T; Francis, RJ; Kler, L; Nussberger, J; Porchet, M; Waeber, B | 1 |
| Barclay, CA; Giannone, C; Gilbert, HB; Moledo, LI; Muscará, M; Sánchez, RA; Traballi, CA | 1 |
| Doorenbos, CJ; van Brummelen, P | 1 |
| Bailey, RR; Swainson, CP; Walker, RJ | 1 |
| Goldszer, RC; Rodriguez, R; Solomon, HS | 1 |
| Ajayi, AA; Elliott, HL; Reid, JL | 1 |
| Fliser, D; Horne, C; Mutschler, E; Nowack, R; Richter, J; Ritz, E | 1 |
| Asakuma, S; Fujiwara, M; Iwasaki, T; Nakamura, K; Nakamura, T | 1 |
| Anderson, PJ; Critchley, JA; Tomlinson, B | 1 |
| Dominiak, P; Gatzka, CE; Häuser, W; Luft, FC; Mann, JF; Schmieder, RE; Schobel, HP | 1 |
| Itoh, H; Murayama, M; Nakayama, M; Osada, N; Sakakibara, M; Suzuki, N; Tanabe, K; Yamada, S; Yamamoto, A; Yamasaki, H; Yokoyama, Y | 1 |
| Ding, JL; Hao, JB; Hao, LR; Ren, LS; Zhang, L | 1 |
8 trial(s) available for aldosterone and cilazapril, anhydrous
| Article | Year |
|---|---|
Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Cilazapril; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Secretion; Male; Middle Aged; Pyridazines; Single-Blind Method | 1991 |
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Double-Blind Method; Drug Administration Schedule; Heart Rate; Humans; Kinetics; Male; Pyridazines; Renin | 1987 |
The effect of acute ACE inhibition on atrial natriuretic peptide.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cilazapril; Heart Rate; Humans; Infusions, Intravenous; Male; Pyridazines; Renin; Renin-Angiotensin System; Sodium | 1989 |
The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Blood Pressure; Cilazapril; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Pyridazines; Random Allocation; Reflex; Renin | 1986 |
Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Cilazapril; Furosemide; Humans; Injections, Intravenous; Kidney; Male; Natriuresis; Peptidyl-Dipeptidase A; Reference Values; Sodium, Dietary | 1993 |
A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Asian People; Blood Pressure; Cilazapril; Electrocardiography; Female; Humans; Male; Peptidyl-Dipeptidase A; Racial Groups; Regression Analysis; Renin; White People | 1996 |
Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output; Catecholamines; Cilazapril; Cohort Studies; Double-Blind Method; Glomerular Filtration Rate; Hemodynamics; Humans; Male; Renal Circulation; Renin; Stress, Psychological | 1996 |
Effects of cilazapril on exercise tolerance in the chronic phase of acute myocardial infarction.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Catecholamines; Cilazapril; Exercise Tolerance; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen Consumption; Renin-Angiotensin System | 1996 |
6 other study(ies) available for aldosterone and cilazapril, anhydrous
| Article | Year |
|---|---|
Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cilazapril; Female; Humans; Isoproterenol; Male; Middle Aged; Pyridazines; Renin-Angiotensin System; Sympathetic Nervous System | 1991 |
Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Female; Humans; Hypertension; Male; Middle Aged; Pyridazines; Renin | 1988 |
Effects of cilazapril on renal function and hormones in hypertensive patients with renal disease.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Pyridazines; Renal Circulation; Renin | 1989 |
Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Cilazapril; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Pyridazines; Renin; Sodium Chloride Symporter Inhibitors | 1988 |
[Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Chronic Disease; Cilazapril; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume | 1995 |
The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Cilazapril; Dialysis Solutions; Disease Models, Animal; Drug Therapy, Combination; Lymphocytes; Macrophages; Male; Mineralocorticoid Receptor Antagonists; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Fibrosis; Peritoneum; Peritonitis; Random Allocation; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Spironolactone; Transforming Growth Factor beta1 | 2014 |